Multifocal radiculoneuropathy during ipilimumab treatment of melanoma.

G, Manousakis; J, Koch; RB, Sommerville; A, El-Dokla; MB, Harms; MT, Al-Lozi; RE, Schmidt; A, Pestronk

doi:10.1002/mus.23830

Public

Multifocal radiculoneuropathy during ipilimumab treatment of melanoma.

Shared by NobleBlocks on Jul 27, 2013 • 12:00 AM UTC

Authors:

Manousakis G

Koch J

Sommerville RB

Abstract

Introduction Ipilimumab, a monoclonal anti-CTLA-4 antibody, is used to treat melanoma. Neuromuscular side effects, possibly autoimmune, may occur.Methods In this investigation we undertook a retrospective review of patient records.Results After 3 doses of ipilimumab, a 31-year-old man developed asym...

Subject

Toxic neuropathy

Ipilimumab

Polyradiculopathy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!